Middle East Pharmaceutical Industries Past Earnings Performance
Past criteria checks 4/6
Middle East Pharmaceutical Industries has been growing earnings at an average annual rate of 17.1%, while the Pharmaceuticals industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 17.1% per year. Middle East Pharmaceutical Industries's return on equity is 25%, and it has net margins of 21.2%.
How Middle East Pharmaceutical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
SASE:4016 Revenue, expenses and earnings (SAR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
493
105
191
0
31 Dec 25
460
97
179
0
30 Sep 25
459
97
177
0
30 Jun 25
432
93
165
0
31 Mar 25
416
90
158
0
31 Dec 24
394
80
154
0
30 Sep 24
387
80
146
0
30 Jun 24
367
79
135
0
31 Mar 24
359
76
128
0
31 Dec 23
338
66
126
0
30 Sep 23
294
41
120
0
30 Jun 23
318
59
122
0
31 Mar 23
291
50
117
0
31 Dec 22
303
59
114
0
31 Dec 21
287
66
98
0
31 Dec 20
302
73
95
0
Quality Earnings: 4016 has high quality earnings.
Growing Profit Margin: 4016's current net profit margins (21.2%) are lower than last year (21.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4016's earnings have grown by 17.1% per year over the past 5 years.
Accelerating Growth: 4016's earnings growth over the past year (16.3%) is below its 5-year average (17.1% per year).
Earnings vs Industry: 4016 earnings growth over the past year (16.3%) exceeded the Pharmaceuticals industry 8.4%.
Return on Equity
High ROE: 4016's Return on Equity (25%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/25 03:59
End of Day Share Price
2026/06/25 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Middle East Pharmaceutical Industries Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.